Mitoxantrone [mitoxantron]
topical
103
- Terms
-
CL-232325
DHAQ
Mitoxantrone Acetate
Mitoxantrone Hydrochloride
Mitozantrone
Mitroxone
Novantron
Novantrone
NSC-279836
NSC-287836
NSC-299195
NSC-301739
NSC-301739D
Onkotrone
Pralifan
Ralenova
Persistent link
https://www.medvik.cz/link/D008942
Definition
An anthracenedione-derived antineoplastic agent.
- DUI
- D008942 MeSH Browser
- CUI
- M0013954
- CAS
- 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-
- Previous indexing
- Anthraquinones (1966-1986)
- History note
- 87
- Public note
- 87
Allowable subheadings
- AD
- administration & dosage 40
- AE
- adverse effects 30
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 4
- PD
- pharmacology 23
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 50
- TO
- toxicity 3
- UR
- urine 1
...
Occurrences in Medvik records